000 01107 a2200301 4500
005 20250513211452.0
264 0 _c20000614
008 200006s 0 0 eng d
022 _a0959-8138
024 7 _a10.1136/bmj.320.7246.1354
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRobinson, N M
245 0 0 _aReperfusion in acute myocardial infarction. Ensuring early reperfusion, by whatever means, is the best strategy for now.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cMay 2000
300 _a1354-5 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAged
650 0 4 _aAngioplasty, Balloon, Coronary
_xeconomics
650 0 4 _aCost-Benefit Analysis
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
_xdrug therapy
650 0 4 _aStents
650 0 4 _aThrombolytic Therapy
_xeconomics
700 1 _aTimmis, A D
773 0 _tBMJ (Clinical research ed.)
_gvol. 320
_gno. 7246
_gp. 1354-5
856 4 0 _uhttps://doi.org/10.1136/bmj.320.7246.1354
_zAvailable from publisher's website
999 _c10769716
_d10769716